Brief: Histogen Announces Board Approval Of Complete Liquidation And Dissolution

Histogen

18/09/2023 22:13

Histogen Inc  HSTO.O :
    * HISTOGEN ANNOUNCES BOARD APPROVAL OF COMPLETE LIQUIDATION
AND
DISSOLUTION
    * HAS DISCONTINUED ALL CLINICAL DEVELOPMENT PROGRAMS AND
REDUCED
ITS WORKFORCE
    * TO DATE, NO VIABLE STRATEGIC ALTERNATIVES ARE AVAILABLE TO
COMPANY
    * CONTINUES TO EXPLORE CERTAIN STRATEGIC OPTIONS THAT MAY BE
AVAILABLE FOR POTENTIAL SALE OF ANY OF ITS PIPELINE ASSETS
    * HISTOGEN REDUCED ITS WORKFORCE, INCLUDING TERMINATION OF
ALL
EMPLOYEES EXCEPT FOR TWO REMAINING EMPLOYEES, EFFECTIVE AS OF
SEPTEMBER 30
    * WORKFORCE REDUCTION INCLUDES TERMINATION OF EMPLOYMENT OF
ALL
OFFICERS EXCEPT FOR SUSAN KNUDSON

Source text for Eikon:  ID:nGNX5d1HQH 
Further company coverage:  HSTO.O